VFA
MNTA

Valeo Financial Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Valeo Financial Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-272
Closed -$5K – 1807
2018
Q1 		$5K Buy
+272
New +$4.54K ﹤0.01% 1168

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Valeo Financial Advisors's MNTA Position: Q2 2018 in Review

Valeo Financial Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2018, closing a stake of 272 shares — an estimated $5K sold.

Valeo Financial Advisors first reported a position in MNTA in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 160 funds tracked by Wall St. Rank hold MNTA as of Q2 2018.

  • Valeo Financial Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Valeo Financial Advisors sold 272 Momenta Pharmaceuticals, Inc. shares in Q2 2018, an estimated $5K.
  • Valeo Financial Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
  • Valeo Financial Advisors's Momenta Pharmaceuticals, Inc. position peaked at $5K in Q1 2018.
  • 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2018.

Based on Valeo Financial Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.